Cellectar Biosciences Inc (CLRB) — Long-term Investment Intensity

Latest as of June 2021: 0.2%

Cellectar Biosciences Inc (CLRB) has a Long-term Investment Intensity of 0.2% as of June 2021. Long-term investments of $75.00K represent 0.2% of total assets of $47.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See CLRB net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

0.2%
LT Investments / Total Assets

Long-term Investments

$75.00K
USD

Total Assets

$47.74 Million
USD

Country

USA
NASDAQ

Cellectar Biosciences Inc Long-term Investment Intensity (2018–2020)

This chart shows how Cellectar Biosciences Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2018 to 2020. As of June 2021, the intensity stands at 0.2%, reflecting long-term investments of $75.00K against total assets of $47.74 Million USD. Also explore CLRB asset base for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Cellectar Biosciences Inc (2018–2020)

The table below presents the year-by-year Long-term Investment Intensity for Cellectar Biosciences Inc from 2018 to 2020, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Cellectar Biosciences Inc market cap and net worth.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2020 0.1% $75.00K $58.66 Million ▼ -0.5 pp
2019 0.6% $75.00K $12.25 Million ▼ -3.0 pp
2018 3.6% $540.82K $15.05 Million
pp = percentage points